Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

CapVest keeps hold of $7bn nuclear medicine company Curium via continuation fund

Private equity firm CapVest will continue to be the majority shareholder of Curium Pharma, the world’s largest pure play nuclear medicine producer, for another three-to-five-year investment round. The company is being moved to a continuation vehicle in a recapitalisation deal that values it at around $7 billion. 
November 27, 2025

KKR leads bid for Star Hospitals, consolidating India’s private hospital sector

Indian multi-speciality hospital group Baby Memorial Hospital (BMH), backed by US private equity firm KKR, is reportedly the leading bidder to acquire Hyderabad-based cardiovascular chain Star Hospitals. The offer is said to value the group at ~₹2,700 crore (~ $302 million). Fortis Hospitals, a for-profit private network with around 6,000 beds, has also been reported as a potential contender, but reports in the Indian media indicate that KKR is the front-runner.
November 27, 2025

UK’s Hg sells Intelerad to GE HealthCare in $2.3bn deal

London-based private equity firm Hg Capital has sold Intelerad, a Montreal-headquartered medical imaging software company, to US healthtech firm GE HealthCare in a deal valued at ~$2.3 billion. Hg is fully exiting its majority stake, while US investors TA Associates and Ardan Equity are selling their minority holdings.
November 27, 2025

AI scribe company Heidi enters SE Asia

Australia-based healthcare AI scribe provider Heidi has opened a new regional headquarters in Singapore, marking its entry into the Southeast Asian market. The move follows a $65 million USD Series B funding round led by Point72 Private Investments, a US-based hedge fund.
November 27, 2025

UK private dentistry could face CMA review over price transparency

UK Chancellor Rachel Reeves has called on the Competition and Markets Authority (CMA), the principal competition regulator in the UK, to launch an investigation into the country’s private dentistry sector, citing concerns over “hidden costs, lack of transparency and overtreatment.”  Letters released by the government reveal that Reeves has asked the regulator to examine how effectively competition operates among private providers and whether patients receive genuine choice and value for money.
November 27, 2025

Increasing demand for GLP-1 drugs driving supply chain consolidation by big pharma

GLP-1s are no longer regarded as “breakthrough treatments"; they are now seen as routine treatments for the management of chronic conditions. The rising demand for GLP-1s has also created pressure on supply chains, prompting increased investment in manufacturing and distribution, and vertical integration by major pharmaceutical companies — something that was highlighted by many speakers at the Jefferies London Healthcare Conference this week. 
November 21, 2025

HBI’s Digital Health Special Report 2025

HBI's first ever Special Report on digital health features analysis and commentary from various experts on the current state of play in digital health, and where the market might be headed, as well as in depth case study interviews with eight different digital health companies, each showcasing a different aspect to healthcare's digital revolution: HealthHero, Kry/Livi, Arts en Zorg, Health Navigator (HN), Helfie AI, Clue, Hellobetter and Flow Neuroscience.
November 20, 2025

Siemens mulls reducing Healthineers stake to minority, Siemens Healthineers continues to mull diagnostics unit sale

German multinational medtech firm Siemens Healthineers is reviewing strategic options for its diagnostics division, including a possible sale. The company stated that its laboratory unit, which supplies a range of technologies to diagnostic labs including equipment and reagents, is being developed under several scenarios and may no longer be the best fit within the group.
November 20, 2025
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us